The models for the Concorde, Rafale, Airbus 380, and all of France’s nuclear missiles are said to have been tested here. READ MORE : https://www.euronews.com/2023/03/25/onera-modane-wind-tunnels-french-alps-where-new-aircraft-models-missiles-get-tested Euronews Next is a future-focused news section covering global innovation, science and technology with a European perspective. Our dedicated team of journalists aims to educate and inspire today’s leaders by providing them with analysis and insights into the people and organisations shaping our future #Mobility

Artificial intelligence (AI) is being used to recreate the sound of family members' voices in order to scam people out of thousands of euros. READ MORE : https://www.euronews.com/2023/03/25/audio-deepfake-scams-criminals-are-using-ai-to-sound-like-family-and-people-are-falling-fo Euronews Next is a future-focused news section covering global innovation, science and technology with a European perspective. Our dedicated team of journalists aims to educate and inspire today’s leaders by providing them with analysis and insights into the people and organisations shaping our future #BiztechNews

Become a patient expert on Regulatory Affairs at EUPATI This module on the EUPATI Open Classroom will give you an overview on medicines regulation including the different marketing authorisation procedures, benefit-risk assessment, pharmacovigilance, pharmacoepidemiology and other relevant aspects, and the role patients can play in these processes.

From new combinations to new applications: #ValueAddedMeds 💊 can improve #access to care but we need them to be supported with regulations and incentives. Hear the suggestions of Arun Narayan, #VAM Sector Group Chair #AccessForAll

Multiple factors, such as a growing and ageing population, the introduction and increased cost of new innovative medicines and the increased chronic disease burden, have put pressure on healthcare budgets across Europe. Therefore, almost all European countries apply strict price regulations to off-patent medicines, with the primary goal to minimise healthcare expenditure. Strict pricing rules for generic medicines to persistently decrease price irrespective of market conditions have been the prime driver of European market and industrial consolidation. This has been exacerbated by the COVID-19 crisis and the war in Ukraine, which has dramatically increased general inflation, as well as cost of goods. Consequently, the security of the medicine supply for the patient is at risk. This shows the need for a shift to pricing policies that ensure healthy market competition and prevent undesired effects of existing pricing mechanisms, allowing patients to continue to have access to a broad range of therapeutic options as well as guaranteeing that generic competition remains healthy on the long term. In this part of the episode, we will explore new pricing policy models that may be an adequate response to deliver a sustainable supply of medicines to patients considering the current circumstances (COVID-19 recovery, inflation, increasing cost of goods).

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

Lativa, Educational Fund, IAS, HIV, AIDS, International AIDS Society, EECA, Eastern Europe HIV, Asia HIV, HIV seminar

The webinar focused on the challenges of diagnosing IgG4-related disease, including the epidemiological features that may help suspect IgG4-related disease, the most common clinical presentations, suggestive laboratory abnormalities, and typical pathology and imaging features. The webinar also covered the disease phenotypes and recently published classification criteria. The final part of the webinar was devoted to updates on therapeutic approaches. After his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology at Vita-Salute San Raffaele University in Milan (Italy), Dr. Della Torre worked for 3 years at the Rheumatology Unit of the Massachusetts General Hospital and at the Ragon Institute of MGH, MIT and Harvard in Boston. Dr. Della Torre returned to Italy in 2018 and established his lab at San Raffale Hospital (Milan, Italy). Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Rheumatology Consultant at San Raffaele Hospital. Dr. Della Torre authored more than 100 scientific publications and achieved prestigious awards such as the Career Research Grant Award from the Foundation for Research in Rheumatology (FOREUM). With his seminal works Dr. Della Torre contributed to the characterization of IgG4-related disease and is currently coordinating the IgG4-related disease Working Group for ERN-ReCONNET.

24 March is the World #Tuberculosis Day. And we can't find a better moment to talk about #TB and the ways of fighting it. So, can we end TB? ECDC expert - Senia Rosales-Klintz tells us that this indeed is the plan, and with a set deadline for 2030. Can we make it? Listen to our episode and find out. If you would like to read the latest news on TB and see the details of the World TB Day campaign, visit our website here. For general information about ECDC, please visit ⁠ecdc.europa.eu⁠, or follow us on ⁠social media⁠: bit.ly/ECDCSocialMedia #WorldTuberculosisDay

1. Reorganisation of EMA Working Parties From 8:40 to 25:23 2. SAWP – interaction with other WPs From 26:33 to 37:32 3. Methodology Working Party From 38:21 to 49:55 4. 3 Rs Working Party From 50:32 to 1:02 5. CAT Feedback From 1:36:42 to 1:46:22 6. CHMP Feedback From 1:46:47 to 1:56:46 7. COMP Feedback From 1:57:12 to 2:13:03 8. HMPC Feedback From 2:13:30 to 2:21:51 9. PDCO Feedback From 2:22:08 to 2:27:50 10. Medical Device Regulation From 2:51:21 to 3:17:37 11. ACT EU Multistakeholder platform: concept paper consultation and kick-off meeting From 3:52:57 to 4:02:02 12. Update and report from Shortage workshop breakout session From 4:18:45 to 4:34:47 13. EMA’s statement on interchangeability of biosimilars From 4:36:09 to 4:43:41 14. Feedback on mini campaigns From 5:06:44 to 5:18:39 15. Multilingualism on the EMA website and in externa communications – a new policy From 5:31:14 to 5:40:38

Benefit from joining My Connect, UEG’s recently innovated exclusive and secure networking platform for searching and linking with international digestive health professionals. Expand your relationships and collaborations and form completely new ones, all in a safe and professional online setting only accessible to those within the myUEG Community. Enhance your connections as well at UEG Week, our renowned annual congress, and enjoy intimate networking opportunities with international colleagues and peers both in-person and online. My Connect features: Live Feed Personalised post creation (images, videos, text) Interest Groups (Women in GI, Young GI, and Researchers Network) Collaborative Forums Direct Messaging (DM) One-on-one Chat My Connect Get connected: https://my.ueg.eu/my-connect #myUEGcommunity #weareUEG

As technology advances rapidly, the disparity between those able to thrive in the job market and those falling behind is growing. ERC grantee Pedro Carneiro, Professor of Economics at University College London, is studying how family dynamics affect the vital skills that children need to achieve success in life. ----------------------------------------------------------------------- Interested in reading more? Visit: https://erc.europa.eu/projects-statistics/stories/closing-skills-gap ------------------------------------------------------------------------ Like our videos? Subscribe to our channel: https://www.youtube.com/europeanresea... ------------------------------------------------------------------------ Find us online Website: https://erc.europa.eu Twitter: https://twitter.com/ERC_Research LinkedIn: https://www.linkedin.com/company/euro... Facebook: https://www.facebook.com/EuropeanRese... ------------------------------------------------------------------------

Silke Gillessen, #:ESMO23 Scientific Chair: From translational research to the sessions that will impact clinical practice today, the ESMO Congress 2023 will cater to every oncologist’s needs. Make sure you are part of the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. Register here: https://www.esmo.org/meeting-calendar/esmo-congress-2023/registration The ESMO Congress 2023: a comprehensive educational and scientific programme will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice-changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. Programme details: https://www.esmo.org/meeting-calendar/esmo-congress-2023/programme Save the date for ESMO 2023, taking place in Madrid, Spain, 20-24 October 2023. https://www.esmo.org/meeting-calendar/esmo-congress-2023 Produced by the European Society for Medical Oncology http://www.esmo.org

Andrés Cervantes, Congress President on #ESMO23: An outstanding scientific and educational programme to serve the oncology community, to provide better care for cancer patients. Make sure you are part of the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. Register here: https://www.esmo.org/meeting-calendar/esmo-congress-2023/registration The ESMO Congress 2023: a comprehensive educational and scientific programme will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice-changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. Programme details: https://www.esmo.org/meeting-calendar/esmo-congress-2023/programme Save the date for ESMO 2023, taking place in Madrid, Spain, 20-24 October 2023. https://www.esmo.org/meeting-calendar/esmo-congress-2023 Produced by the European Society for Medical Oncology http://www.esmo.org

Karin Jordan, #ESMO23 Educational Chair, invites you to join the nearly 30,000 professionals who will learn about the latest practice challenges and controversies in oncology today. Make sure you are part of the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. Register here: https://www.esmo.org/meeting-calendar/esmo-congress-2023/registration The ESMO Congress 2023: a comprehensive educational and scientific programme will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice-changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. Programme details: https://www.esmo.org/meeting-calendar/esmo-congress-2023/programme Save the date for ESMO 2023, taking place in Madrid, Spain, 20-24 October 2023. https://www.esmo.org/meeting-calendar/esmo-congress-2023 Produced by the European Society for Medical Oncology http://www.esmo.org

Ramadan calls on Muslims to fast from sunrise to sunset - but what about patients on diabetes drugs or other medications? READ MORE : https://www.euronews.com/2023/03/22/ramadan-fasting-rules-how-do-muslims-with-chronic-diseases-manage-their-medications Euronews Next is a future-focused news section covering global innovation, science and technology with a European perspective. Our dedicated team of journalists aims to educate and inspire today’s leaders by providing them with analysis and insights into the people and organisations shaping our future #Health

With Europe's climate change targets, 35 million buildings are expected to be renovated by 2030, and many workers risk being exposed to asbestos. READ MORE : https://www.euronews.com/2023/03/22/why-must-asbestos-regulations-change-to-better-protect-eu-workers Euronews Next is a future-focused news section covering global innovation, science and technology with a European perspective. Our dedicated team of journalists aims to educate and inspire today’s leaders by providing them with analysis and insights into the people and organisations shaping our future #Realeconomy

Asbestos has been banned in the EU since 2005 but the material is still present in old buildings. It poses a serious health threat and can cause inflammation, scarring and cancer when inhaled. We asked a specialist about the best way to get rid of it safely. READ MORE : https://www.euronews.com/2023/03/22/what-should-i-do-if-i-discover-asbestos-heres-how-to-deal-with-it-safely Euronews Next is a future-focused news section covering global innovation, science and technology with a European perspective. Our dedicated team of journalists aims to educate and inspire today’s leaders by providing them with analysis and insights into the people and organisations shaping our future #Realeconomy

The Knowledge Valorisation Platform connects players in Europe with the ambition to turn research results into sustainable products and solutions for the future. Learn about this stakeholder forum and what it offers for you. Join at: https://research-and-innovation.ec.europa.eu/research-area/industrial-research-and-innovation/eu-valorisation-policy/knowledge-valorisation-platform_en

Consumers lack reliable information about how sustainable a product is, and often are confronted with misleading commercial practices like greenwashing. This is why clear methods for companies to substantiate the environmental impacts or benefits of their products or organisations are needed! Our researchers developed the Environmental Footprint Method. It allows to account for impacts of products across their full life cycle, measuring all the emissions and resources consumed starting from extraction of raw materials, through production and use, and up to final waste management. Read more: https://eplca.jrc.ec.europa.eu/EnvironmentalFootprint.html

A one-size-fits-all approach cannot work for all patients and this why #ValueAddedMeds💊 can meet their needs with a new approach and innovative solutions💡- as our #VAM Sector Group Chair, Arun Narayan explains #AccessForAll

What can we do to avoid medicines #shortages?

Presented by Jonathan Tedds (ELIXIR Programme Manager for Scientific Computing) 16th March 2023 This is part of a series of webinars outlining the different aspects of the Tech Team, more information: https://elixir-europe.org/events/elixir-tech-team-webinars-series

The European Centre for Disease Prevention and Control (ECDC) will hold a press briefing to mark the World Tuberculosis day and provide an update on the latest surveillance and monitoring data (2021) and current TB situation in Europe. Speakers: ➡ Andrea Ammon - ECDC Director ➡ Marieke van der Verf - Head of Section STI, Blood-Borne Viruses and TB Moderation: ➡ Andrea Horvat-Kramaric - ECDC Spokesperson.

On this episode we are speaking with Cornelia Adlhoch again, and discussing the avian influenza outbreak, its spread to other animals, and whether we should worry about it spreading further. If you would like to read more about the latest report about the ongoing avian influenza outbreaks in birds, you can find it here: bit.ly/ECDCAvianFlu2023 If you would like to know more about EFSA, listen to their podcast "Science on the Menu":https://www.efsa.europa.eu/en/news/science-on-the-menu-podcast You can also hear Cornelia's previous episode on Avian flu here: bit.ly/ECDConAir15 For general information about ECDC, please visit ecdc.europa.eu, or follow us on social media: bit.ly/ECDCSocialMedia

The event will provide potential applicants with specific information on the Global Health EDCTP3 calls for proposals, in particular the two-stage calls, under Work Programme 2023, as well as information on eligibility criteria and other relevant administrative matters. More information: https://research-innovation-community.ec.europa.eu/events/2z4gjuKMuSQNtq0mIAIFR9/overview

More information on the event page: https://ec.europa.eu/research/participants/docs/h2020-funding-guide/other/event230321.htm

The Spring Budget was a key moment for the life sciences sector following the R&D tax relief rate cut announced at the November 17 Autumn Statement. The Chancellor has since written to BIA stating that he sees “merit” in the case for further support for life science SMEs impacted by the cut, but the demands on the UK’s public finances leave significant uncertainty in what can be delivered.   Hear from BIA’s team that has been campaigning on behalf of the sector about their analysis of any further support delivered, as well as the wider reforms to the R&D tax relief regime underway.

During the webinar, we will discuss the high frequency and multifactorial nature of fatigue in those affected by systemic lupus erythematosus (SLE). We will highlight the contribution of various factors such as disease activity, depression, anxiety and pain and show how these factors combine together to trigger fatigue in SLE. With Lou Kawka (MD), we will show how we have developed LEAF, the Lupus Expert System for Fatigue, an innovative digital tool providing personalized assessment of fatigue, as well as individualized advice for the management of fatigue. Laurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University (Unistra) & Academic Hospitals, France. His main clinical interests focus on the care of patients with Systemic Lupus Erythematosus (SLE). He is leading a research group focusing on innovative strategies to study the epidemiology of autoimmune diseases, with a particular interest for the use of novel diagnostic and therapeutic digital strategies based on big data and Artificial Intelligence. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has contributed to more than 200 research projects in the field of rare diseases. Professor Arnaud is the President-Elect of the European Lupus Society (SLEuro) and Disease Coordinator for Lupus and relapsing polychondritis of the European Reference Network for rare diseases ReCONNET. He is the curator of a twitter account (@Lupusreference) about lupus education, followed by more than 12.5k people. Lou Kawka (MD) is a resident in Rheumatology, currently pursuing her medical formation at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), at the University Hospital of Strasbourg, France. Her main clinical interest is the care of patients with chronic immunological diseases. With Laurent Arnaud (MD, PhD), she has developed LEAF, the Lupus Expert System for the Assessment of Fatigue, an innovative digital tool providing personalized recommendations to cope with fatigue. She has also obtained a master’s degree in Biomedical Research while studying the implication of innate immunity in the pathogenesis of Sjögren’s syndrome in the Molecular and Cellular Biology Institute of Strasbourg (IBMC).

Do you know what a biosimilar medicine is? Listen to EMA's Chief Medical Officer, Steffen Thirstrup, for an overview of what they are and how they work. Read more about Biosimilars: https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview

In the European Union, biosimilar medicines are interchangeable. Watch EMA's Chief Medical Officer, Steffen Thirstrup, explain that is it safe to interchange biosimilars. Read more about Biosimilars: https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview

Did you know that the European Medicines Agency (EMA) also assesses vaccines and medicines to be used outside of the European Union? Learn more about the EU-M4all initiative with Martin Harvey, Head of International Cooperation at EMA. More information about EU-M4all: https://www.ema.europa.eu/en/partners-networks/international-activities/medicines-assessed-under-eu-m4all-procedure

UKRI’s Strategy engagement event in Dundee brought together academics, policymakers, and business leaders across Scotland. The theme of the event was world-class ideas and it focused on how Scotland can continue to harness the power of some of its most impressive assets. This includes the creativity and ingenuity of its talented researchers and innovators, and the many people, in many roles, with whom they work. The event included a tour of InGAME, a Dundee-based research and development centre and part of the Creative Industries Clusters Programme, funded by UKRI through AHRC. InGame shows how video game design techniques, tools and technologies can be used to solve real-world problems. And a visit to the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU), a world-leader in finding the causes of neurodegeneration, cancer, hypertension and immune disorders. The unit’s leading expertise, housed in Dundee, has been instrumental in the establishment of world’s longest running collaboration between academic research laboratories and the pharmaceutical industry. This has yielded important results including an approved drug for treatment of a specific type of skin cancer. ------------------------------------------------------------------------------------------------------------------------------------------------------------- We are UK Research and Innovation, the body that allocates government funds for research. If you're a UK tax payer, your contributions help fund the work we showcase on our channel. And if you liked this video, follow us on these channels: Medium: https://medium.com/@UKRI Instagram: https://www.instagram.com/weareukri/ Facebook: https://www.facebook.com/weareUKRI YouTube:  https://youtube.com/c/UKResearchandInnovation Or sign up for our weekly newsletter https://public.govdelivery.com/accounts/UKRI/subscriber/new?topic_id=UKRI_newsletter

How do you make sure your presentation fits the format? How is preparing for a 2-minute talk different to a 10-minute talk? What should be the focus of a poster, compared to supporting materials? In this webinar, researcher and graphic designer Fabio Crameri and scientists Maria-Helena Ramos share the key tips for creating a powerful and effective presentation over four key formats. Using a single study, the speakers will share how your research should be communicated through four different presentation styles: 2-minute talks, 10-minute talks, posters, and supporting material. The webinar will last one hour, with approximately 40 minutes for presentations and 20 minutes for audience Q&A. Fabio Crameri produces freelance research and science-related graphic design, and gives masterclasses in science communication. One of his current projects is “’s-ink.org”, the open-access and community-reviewed sharing platform for science-grade graphics. Maria-Helena Ramos is a research scientist in hydrology at INRAE in France. Her research focuses on flood and drought forecasting, and on the use of probabilistic predictions to inform decision making in water resources management. She is currently the president of the EGU Division on Hydrological Sciences and Co-chair of the Programme Committee for the EGU23 General Assembly. For more information about future webinars visit: https://www.egu.eu/webinars/ Follow us: Twitter: https://twitter.com/EuroGeosciences Instagram: https://www.instagram.com/eurogeoscie... Facebook: https://www.facebook.com/EuropeanGeos... LinkedIn: https://www.linkedin.com/company/2338760 Website: https://www.egu.eu Email: [email protected]

This event aims to kick-start the formation of a community of practice between cultural heritage professionals and demonstrate how the European Collaborative Cloud for Cultural Heritage can be useful in their everyday work. More information: https://research-innovation-community.ec.europa.eu/events/13RqOjrNgOrkH49gjMVavN/overview

This event aims to kick-start the formation of a community of practice between cultural heritage professionals and demonstrate how the European Collaborative Cloud for Cultural Heritage can be useful in their everyday work. More information: https://research-innovation-community.ec.europa.eu/events/13RqOjrNgOrkH49gjMVavN/overview

This event aims to kick-start the formation of a community of practice between cultural heritage professionals and demonstrate how the European Collaborative Cloud for Cultural Heritage can be useful in their everyday work. More information: https://research-innovation-community.ec.europa.eu/events/13RqOjrNgOrkH49gjMVavN/overview

This event aims to kick-start the formation of a community of practice between cultural heritage professionals and demonstrate how the European Collaborative Cloud for Cultural Heritage can be useful in their everyday work. More information: https://research-innovation-community.ec.europa.eu/events/13RqOjrNgOrkH49gjMVavN/overview

This event aims to kick-start the formation of a community of practice between cultural heritage professionals and demonstrate how the European Collaborative Cloud for Cultural Heritage can be useful in their everyday work. More information: https://research-innovation-community.ec.europa.eu/events/13RqOjrNgOrkH49gjMVavN/overview